It is reported that recently, with the change of China's prevention and control policies related to the epidemic, it has attracted much attention. Countries and groups, including the United States and WHO, expressed "concern" about the epidemic in China and called for its control as soon as possible. On last Thursday, Indian Foreign Ministry spokesman Bach also shouted to China that India was "ready to help China". India, known as the "world pharmacy", has been helping other countries, and now is also concerned about the epidemic situation in China. India's "help" refers to antipyretic drugs, because the official of the drug export department said that they were consulting the price of antipyretic drugs on the same day to facilitate the export to China.
The report mentioned that there are two reasons why India is confident to export antipyretic drugs to China. First, they have developed the pharmaceutical industry for a long time in the past, and the pharmaceutical OEM field has always been in the forefront of the world. Many western countries contract patented drugs to India for production; Second, because of the epidemic situation in India in the past two years, there are many antipyretic drugs and a large number of "stocks" in India, and the production lines for pharmaceutical use are still sufficient. At present, the Indian government has normalized epidemic management, completely cancelled the provision of online health declaration for inbound passengers, and is basically in a "fully open" state on border issues.
Later on the 24th, Indian media reported another news: the government decided to resume the requirement of "mandatory submission of nucleic acid reports" for passengers from four countries, involving China, Japan, South Korea and Thailand. Visitors from countries on the list must log on to the Indian government website and submit nucleic acid reports before entering the country, and also check their body temperature when the flight arrives; India stipulates that if positive cases are found among passengers from four countries after entry, the quarantine policy will be implemented. In addition, the Indian government also mentioned that if they were not tourists from these four countries, they would implement "two percent sampling test" to control the epidemic. This is the first country in the world to carry out epidemic prevention and control "for specific groups" recently, which has aroused heated public opinion.
The Hindustan Times and other media, when reporting the news, especially said that India had to introduce these measures because of the surge in cases in China and its concern about "causing the fourth wave of epidemic in the country to rage"; Similarly, for countries such as Japan and South Korea where the epidemic situation is still rampant, the Indian government also needs to carry out "necessary prevention and control". The conditions for compulsory nucleic acid and compulsory isolation proposed by Health Minister Mandavia are all right. However, there are also doubts that India's method is not appropriate, and they should provide sufficient evidence documents for "specific groups to restore isolation and nucleic acid", because other western countries COVID-19 are also increasing seriously, and do not implement the same standard to treat suspected "discrimination".
Others believe that, as far as the current situation is concerned, the new reports in India are relatively low, and the actual number of COVID-19 infections is relatively high, so it is unnecessary to implement the policy of "differential treatment" for tourists from all countries; Moreover, if we want to avoid the spread abroad, we will only implement strict policies on China, Japan and other countries, and have no effect on "sampling 2%" of other countries. The virus will still enter from abroad. There was also a comment on this: "Whether in the past or now, India is not a 'successful epidemic prevention' country. In the sampling report of New Delhi last year, more than 70% of the samples of infected people were detected, indicating that the epidemic has become very common, and it is not significant not to do so. Moreover, Japan, South Korea and other countries have reached the peak, and now they are banned by the Ministry of Health of India. Is it too late?"

Wenzhou SICO Spraying Tech.Co.,Ltd is engaged in the research,development,manufacturing and marketing of air painting spray gun series,Pneumatic tools,Air filterCombination,and Air fitting and Accessories.Aimed at customers’ satisfaction,SICO has continuously provided various customers with all-round solutions for spraying products.If you have any question,You can find me in these ways.
Mrs.Cindy Email:Sales@sicotools.com
Whatsapp:+8615158537263
...
These SK-300 spray guns are fantastic! Love the no oring design, less leakage and easy maintenance. The atomization is perfect for automotive painting. Highly recommend!
Spiro Pittas,AustraliaPRD-817 gives me precise control over color, gloss, and gradients-art-level finish without top-tier pricing”
Olie-PaintzPRD-817 gives me precise control over color, gloss, and gradients-art-level finish without top-tier pricing”
Olie-PaintzPRD-817 gives me precise control over color, gloss, and gradients-art-level finish without top-tier pricing”
Olie-PaintzPRD-817 gives me precise control over color, gloss, and gradients-art-level finish without top-tier pricing”
Olie-Paintz